"Biomarqueurs - Chat. "
Bibliographie
1. Zimmering TM, Meneses F, Nolte IJ, Simon D. Measurement of N-terminal proatrial natriuretic peptide in plasma
of cats with and without cardiomyopathy. Am J Vet Res. Feb 2009, Vol. 70(2), pp. 216-22.
2. Yap LB, Mukerjee D, Timms PM, Ashrafian H, Coghlan JG. Natriuretic peptides, respiratory disease, and the right
heart. Chest. Oct 2004, Vol. 126(4), pp. 1330-6.
3. Wagner T, Fuentes VL, McDermott N, Payne R. Association between cardiac murmurs and left ventricular
hypertrophy in 199 healthy adult cats. Proceedings of the 19th Annual ECVIM Congress. Porto, Portugal. Sep 8-10,
2009, p. 14. [Abstract].
4. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W,
Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting
survival in patients with chronic heart failure. J Am Coll Cardiol. Nov 13, 2007, Vol. 50(20), pp. 1973-80.
5. van Kimmenade RRJ, Pinto YM, Januzzi JL Jr. Importance and Interpretation of intermediate (gray zone) Aminoterminal Pro-B-type Natriuretic Peptide Concentrations. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 39-42.
6. van Kimmenade RRJ, Januzzi JL Jr. The evolution of the natriuretic peptides - Current applications in human and
animal medicine. J Vet Cardiol. May 2009, Vol. 11 Suppl 1, pp. S9-21.
7. Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by aminoterminal Pro-B-type Natriuretic Peptide measurement. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 72-5.
8. Tessier-Vetzel, D. Endothélines et peptides natriurétiques une prise en charge de l'insuffisance cardiaque. Action
vét. Edition spéciale Cardiologie, Oct 2002, pp. 20-23.
9. Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med. Sep-Oct 2001,
Vol. 15(5), pp. 501-3.
10. Sisson D, Oyama MA, PF Solter. Plasma levels of ANP, BNP, epinephrine, norepinephrine, serum aldosterone,
and plasma renin activity in healthy cats and cats with myocardial disease. J Vet Intern Med. 2003, Vol. 17, pp. 43839. [Abstract].
11. Schoeber KE, Kirbach B, Cornand C, Oechtering G. Circulating Cardiac Troponins in Small Animals. Proceedings of
the 19th Annual Veterinary Medical ACVIM Forum. Denver CO. May 23-26, 2001, pp. 91-92.
12. Rishniw M, Barr SC, Simpson KW, Winand NJ, Wootton JA. Cloning and sequencing of the canine and feline
cardiac troponin I genes. Am J Vet Res. 2004 Jan;65(1):53-8. Jan 2004, Vol. 65(1), pp. 53-8. Erratum in: Am J Vet Res.
2004 Mar;65(3):343.
13. Reynolds C, Oyama M. Intérêt des biomarqueurs en cardiologie. Veterinary Focus. 2008, Vol. 18(3), pp. 2-6.
14. Prosek R, Sisson DD, Oyama MA, Biondo AW, Solter PE. Measurements of plasma endothelin immunoreactivity
in healthy cats and cats with cardiomyopathy. J Vet Intern Med. Nov-Dec 2004, Vol. 18(6), pp. 826-30.
15. Porciello F, Rishniw M, Herndon WE, Birettoni F, Antognoni MT, Simpson KW. Cardiac troponin I is elevated in
dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease. Aust Vet J. Oct 2008, Vol.
86(10), pp. 390-4.
16. Porcher, O.F. Les peptides natriurétiques et leur rôle dans l'insuffisance cardiaque. [Thèse de Doctorat
Vétérinaire (Maison-Alfort)]. 2000. 134 pages.
17. Paige CF, Abbott JA, Elvinger F, Pyle RL. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med
Assoc. June 1, 2009, Vol. 234(11), pp. 1398-403. comments in J Am Vet Med Assoc. 2009 Aug.1; 235(3) : 263-4 & J
Am Vet Med Assoc. 2009 Sept. 15; 235(6) : 659.
18. Ordonez-Llanos J, Collinson PO, Christenson RH. Amino-terminal Pro-B-type Natriuretic Peptide: Analytic
Considerations. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 9-15.
19. Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall
C, Pfeffer MA, Braunwald E and Investigators, PEACE. Prognostic Value of B-Type Natriuretic Peptides in Patients
With Stable Coronary Artery Disease. The PEACE Trial. J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.
Jul 17, 2007, Vol. 50(3), pp. 205-14. Comment in: J Am Coll Cardiol. 2007 Jul 17;50(3):215-6.
20. O'Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a
cardiac troponin I immunoassay. Clin Chem. Dec 1997, Vol. 43(12), pp. 2333-8.
21. O'Brien PJ, Dameron GW, Beck ML, Brandt M. Differential reactivity of cardiac and skeletal muscle from various
species in two generations of cardiac troponin-T immunoassays. Research in Veterinary Science. 1998, Vol. 65, pp.
135-7.
22. Nowatzke WL, Cole TG. Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and
after multiple freeze-thaw cycles. Clin Chem. Sep 2003, Vol. 49(9), pp. 1560-2.
23. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M,
Nakanishi N, Takamiya M, Kunieda T, Matsuo H, Kangawa K. Plasma brain natriuretic peptide levels increase in
proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol. Jan 1998, Vol.
31(1), pp. 202-8.
24. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, Ford I, McMurray JJ, Dargie HJ. Brain
natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical
practice. Heart. Dec 1997, Vol. 78(6), pp. 594-7.
25. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Comparison of the Biomedica NT-proBNP Enzyme
Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of
Symptomatic and Asymptomatic Structural Heart Disease. Clin Chem. 2003, Vol. 49(6), pp. 976-9.
26. Masson S, Latini R. Amino-terminal Pro-B-type Natriuretic Peptides and prognosis in chronic heart failure. Am J
Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 56-60.
27. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. Biology of the Natriuretic Peptides. Am J Cardiol.
Feb 4, 2008, Vol. 101(3A), pp. 3-8.
28. MacLean HN, Abbott JA, Ward DL, Huckle WR, Sisson DD, Pyle RL. N-terminal atrial natriuretic peptide
immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med. Mar-Apr 2006, Vol. 20(2),
pp. 284-9.
29. MacDonald KA, Klose TC,Munro CJ, Kittleson MD. The effect of long term storage on the concentration of Brain
Natriurtic Peptide in frozen plasma of cats. Proceedings of the 23rd Annual ACVIM Forum. Baltimore MD. June 1-4,
2005. [Abstact #184].
30. MacDonald KA, Kittleson MD, Larson RF, Kass P, Klose T, Wisner ER. The effect of ramipril on left ventricular
mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial
hypertrophic cardiomyopathy without heart failure. J Vet Intern Med. 2006 Sep-Oct;20(5):1093-105. Sep-Oct 2006,
Vol. 20(5), pp. 1093-105.
31. MA, Oyama. Using BNP tests in dogs & cats with heart disease. Proceedings of the 26th Annual Veterinary
Medical ACVIM Forum. San Antonio, TX. Jun 4-7, 2008, pp. 105-6.
32. Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptides for diagnostic use are dependent on
age, gender and heart rate. Eur J Heart Fail. Oct 2003, Vol. 5(5), pp. 599-606.
33. Liu ZL, Wiedmeyer CE, Sisson DD, Solter PF. Cloning and characterization of feline brain natriuretic peptide.
Gene. Jun 12, 2002, Vols. 292(1-2), pp. 183-90.
34. Lefevre C, Goby L. Le tout premier symposium sur l'endocardiose mitrale chez le chien ouvre de nouveaux
horizons dans le domaine de la recherche, des soins et du traitement. Prat. Vét. Anim. Cie. Avril 2005, Vol. 15 suppl
24, pp. 11-15.
35. Lang K, Börner A, Figulla HR. Comparison of biochemical markers for the detection of minimal myocardial injury:
superior sensitivity of cardiac troponin--T ELISA. J Intern Med. Jan 2000, Vol. 247(1), pp. 119-23.
36. Lalor SM, Connolly DJ, Elliott J, Syme HM. Plasma concentrations of natriuretic peptides in normal cats and
normotensive and hypertensive cats with chronic kidney disease. J Vet Cardiol. 2009 May;11 Suppl 1:S71-9. May
2009, Vol. 11 Suppl 1, pp. S71-9.
37. Korff S, Katus HA, Giannitsis E. Differential DIagnosis of elevated troponins. Heart. 2006, Vol. 92, pp. 987-93.
38. Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction:
comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction
Peptide) study. J Am Coll Cardiol. May 13, 2008, Vol. 51(19), pp. 1857-64.
39. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, Lövgren T, Bulargina TV,
Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB. Degradation of cardiac troponin I: implication for
reliable immunodetection. Clin Chem. 1998, Vol. 44(12), pp. 2433-40.
40. K, Khan. Is BNP ready for use in clinical practice? Heart. Aug 1999, Vol. 82(2), pp. 254-5.
41. JR, Turk. Physiologic and pathophysiologic effects of natriuretic peptides and their implications in
cardiopulmonary disease. J Am Vet Med Assoc. Jun 15, 2000, Vol. 216(12), pp. 1970-6.
42. J-Ph, Roy. Les peptides natriurétiques atriaux : biologie et principaux rôles physiologiques. Revue Med. Vét. 1998,
Vol. 149(11), pp. 999-1006.
43. Januzzi JL Jr, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis
or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 29-38.
44. Hyman AL, De Witt BJ, Gumusel B, Hao Q, Kadowitz PJ, Lippton HL. L-NAME enhances responses to atrial
natriuretic peptide in the pulmonary vascular bed of the cat. J Appl Physiol. Jun 2001, Vol. 90(6), pp. 2101-8.
45. Hsu A, Kittleson MD, Paling A. Investigation into the use of plasma NT-proBNP concentration to screen for feline
hypertrophic cardiomyopathy. J Vet Cardiol. May 2009, Vol. 11 Suppl 1, pp. S63-70.
46. Hori Y, Yamano S, Iwanaga K, Kano T, Tanabe M, Uechi M, Kanai K, Nakao R, Hoshi F, Higuchi S. Evaluation of
plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. J Vet Intern Med. Jan-Feb
2008, Vol. 22(1), pp. 135-9.
47. Herndon WE, Rishniw M, Schrope D, Sammarco CD, Boddy KN, Sleeper MM. Assessment of plasma cardiac
troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats. J Am Vet Med
Assoc. Oct 15, 2008, Vol. 233(8), pp. 1261-4.
48. Herndon WE, Kittleson MD, Sanderson K, Drobatz KJ, Clifford CA, Gelzer A, Summerfield NJ, Linde A, Sleeper
MM. Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med. Sep-Oct 2002, Vol. 16(5), pp. 55864.
49. Gobinet A, Valli N, Bordenave L. Le facteur natriurétique de type B (BNP) en cardiologie : de l'outil diagnostique
à l'hormone médicament. Revue de l'ACOMEN. 2000, Vol. 6, 2.
50. GA, Sagnella. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci
(Lond). Nov 1998, Vol. 95(5), pp. 519-29.
51. Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE,
Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF. Utility of
plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and
non-cardiac causes of acute dyspnea in cats. J Vet Cardiol. May 2009, Vol. 11 Suppl 1, pp. S51-61.
52. Fox PR, Oyama MA, MacDonald K. Comparison of NT-proBNP concentration in cats with acute dyspnea from
cardiac or respiratory disease. Proceedings of the 26th Annual Veterinary Medical ACVIM Forum. San Antonio, TX.
Jun 4-7, 2008, p. 719. [Abstract].
53. Ertugrul DT, Yavuz B, Ata N, Yalcin AA, Kucukazman M, Algul B, Dal K, Akin KO, Deveci OS, Canbolat N, Ure OS,
Tutal E. Decreasing Brain Natriuretic Peptide Levels after Treatment for Hyperthyroidism. Endocr J. 2009. Advance
Publication : 2009 Sep 9. [Epub ahead of print].
54. DeFilippi C, van Kimmenade RRJ, Pinto YM. Amino-terminal Pro-B-type Natriuretic Peptide testing in renal
disease. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 82-8.
55. D, Sisson. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract. Sep 2004, Vol.
34(5), pp. 1105-26.
56. —. B-type natriuretic peptides. J Vet Cardiol. May 2009, Vol. 11 Suppl 1, pp. S5-7.
57. Connolly DJ, Soares Magalhaes RJ, Syme HM, Boswood A, Luis Fuentes V, Chu L, Metcalf M. Circulating
Natriuretic Peptides in Cats with Heart Disease. J Vet Intern Med. 2008, Vol. 22, pp. 96-105.
58. Connolly DJ, Soares Magalhaes RJ, Fuentes VL, Boswood A, Cole G, Boag A, Syme HM. Assessment of the
diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and
non-cardiac causes of respiratory distress. J Vet Cardiol. May 2009, Vol. 11 Supl 1, pp. S41-50.
59. Connolly DJ, Guitian J, Boswood A, Neiger R. Serum troponin I levels in hyperthyroid cats before and after
treatment with radioactive iodine. J Feline Med Surg. Oct 2005, Vol. 7(5), pp. 289-300.
60. Connolly DJ, Cannata J, Boswood A, Archer J, Groves EA, Neiger R. Cardiac troponin I in cats with hypertrophic
cardiomyopathy. J Feline Med Surg. Aug 2003, Vol. 5(4), pp. 209-16.
61. Cleland JG, Ward S, Dutka D, Habib F, Impallomeni M, Morton IJ. Stability of plasma concentrations of N and C
terminal atrial natriuretic peptides at room temperature. Heart. Apr 1996, Vol. 75(4), pp. 410-3. Comment in: Heart.
1996 Apr;75(4):410-3.
62. Christ-Crain M, Morgenthaler NG, Meier C, Müller C, Nussbaumer C, Bergmann A, Staub JJ, Müller B. Pro-Atype and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Med Wkly. Sep 17,
2005, Vols. 135(37-38), pp. 549-54.
63. Cauliez B, Berthe MC, Lavoinne A. Le BNP : aspects physiologiques, biologiques et cliniques. Ann Biol Clin. 2005,
Vol. 63(1), pp. 15-25. Revue générale.
64. C, Mueller. The use of B-type Natriuretic Peptides in Coronary Artery Disease - Utile or futile ? J Am Coll Cardiol.
July 17, 2007, Vol. 50(3), pp. 215-6. [Editorial comment].
65. Buckley MG, Marcus NJ, Yacoub MH. Cardiac peptide stability, aprotinin and room temperature: importance for
assessing cardiac function in clinical practice. Clin Sci (Lond). 97(6), Dec 1999, pp. 689-95.
66. Bomassi E, Rousselot J-F. Les marqueurs biologiques en Cardiologie : le NT-proBNP et la troponine I. PratiqueVet.
2008, Vol. 43, pp. 618-621.
67. Biondo AW, Wiedmeyer CE, Sisson DD, Solter PF. Comparative sequences of Canine and Feline Endothelin-1. Vet
Clin Pathol. 2003, Vol. 32(4), pp. 188-94.
68. Biondo AW, Liu ZL, Wiedmeyer CE, de Morais HS, Sisson DD, Solter PE. Genomic sequence and cardiac
expression of atrial natriuretic peptide in cats. Am J Vet Res. Feb 2002, Vol. 63(2), pp. 236-40.
69. Biondo AW, Ehrhart EJ, Sisson DD, Bulmer BJ, De Morais HS, Solter PF. Immunohistochemistry of Atrial and
Brain Natriuretic Peptides in Control Cats and Cats with Hypertrophic Cardiomyopathy. Vet Pathol. Sep 2003, Vol.
40(5), pp. 501-6.
70. Bettencourt P, Januzzi JL Jr. Amino-terminal pro-B-type Natriuretic Peptide testing for inpatient monitoring and
treatment guidance of acute destabilized Heart Failure. Am J cardiol. Feb 4, 2008, Vol. 101(3A), pp. 67-71.
71. Bayes-Genis A, DeFilippi C, Januzzi JL Jr. Understanding amino-terminal Pro-B-type Natriuretic Peptide in
Obesity. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 89-94.
72. Baggish AL, van Kimmenade RRJ, Januzzi JL Jr. The différential diagnosis of an elevated amino-terminal Pro-Btype Natriuretic Peptide level. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 43-8.
73. —. Amino-terminal Pro-B-type Natriuretic Peptide testing and prognosis in patients with acute dyspnea,
including those with acute heart failure. Am J Cardiol. Feb 4, 2008, Vol. 101(3A), pp. 49-55.
74. Baggish AL, Siebert U, Lainchbury JG, Cameron R, Anwaruddin S, Chen A, Krauser DG, Tung R, Brown DF,
Richards AM, Januzzi JL Jr. A validated clinical and biochemical score for the diagnosis of acute heart failure: the
ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J. Jan
2006, Vol. 151(1), pp. 48-54.
75. Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R. Hyperthyroidism may affect serum N-terminal pro-B-type
natriuretic peptide levels independently of cardiac dysfunction. Clin Endocrinol (Oxf). Aug 2007, Vol. 67(2), pp. 202-7.
76. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr. Renal Function,
CHF, and Amino-Terminal Pro-BNP Measurement Results From the ProBNP Investigation of Dyspnea in the
Emergency Department (PRIDE) Study. J Am Coll Cardiol. Jan 3, 2006, Vol. 47(1), pp. 91-7.
77. Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy
H. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
Biomed Pharmacother. Jan-Feb 2005, Vols. 59(1-2), pp. 20-4.
78. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipälä J, Ruskoaho H, Leppäluoto J, Vuolteenaho O. Molecular
heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type
natriuretic peptides. Clin Chem. Sep 2004, Vol. 50(9), pp. 1576-88.
79. Adin DB, Milner RJ, Berger KD, Engel C, Salute M. Cardiac troponin I concentrations in normal dogs and cats
using a bedside analyzer. J Vet Cardiol. May 2005, Vol. 7(1), pp. 27-32.
80. A, Boswood. Biomarkers in cardiovascular disease: beyond natriuretic peptides. J Vet Cardiol. May 2009, Vol. 11
Suppl 1, pp. S23-32.